Literature DB >> 1723636

Hormonal manipulation of prostatic cancer.

F H Schröder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1723636      PMCID： PMC1671807          DOI： 10.1136/bmj.303.6816.1489

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  15 in total

1.  Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer.

Authors:  J Waxman; A Man; W F Hendry; H N Whitfield; G M Besser; R C Tiptaft; A M Paris; R T Oliver
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-16

2.  Orchiectomy versus oestrogen in the treatment of advanced prostatic cancer.

Authors:  R Haapiainen; S Rannikko; M Ruutu; M Ala-Opas; E Hansson; H Juusela; J Permi; M Saarialho; J Viitanen; O Alfthan
Journal:  Br J Urol       Date:  1991-02

3.  A controlled trial of leuprolide with and without flutamide in prostatic carcinoma.

Authors:  E D Crawford; M A Eisenberger; D G McLeod; J T Spaulding; R Benson; F A Dorr; B A Blumenstein; M A Davis; P J Goodman
Journal:  N Engl J Med       Date:  1989-08-17       Impact factor: 91.245

Review 4.  Sudden death due to disease flare with luteinizing hormone-releasing hormone agonist therapy for carcinoma of the prostate.

Authors:  I M Thompson; E J Zeidman; F R Rodriguez
Journal:  J Urol       Date:  1990-12       Impact factor: 7.450

5.  The response of metastatic adenocarcinoma of the prostate to exogenous testosterone.

Authors:  J E Fowler; W F Whitmore
Journal:  J Urol       Date:  1981-09       Impact factor: 7.450

6.  A comparison of diethylstilbestrol or orchiectomy with buserelin and with methotrexate plus diethylstilbestrol or orchiectomy in newly diagnosed patients with clinical stage D2 cancer of the prostate.

Authors:  R P Huben; G P Murphy
Journal:  Cancer       Date:  1988-11-01       Impact factor: 6.860

7.  Low androgen levels induce the development of androgen-hypersensitive cell clones in Shionogi mouse mammary carcinoma cells in culture.

Authors:  F Labrie; R Veilleux; A Fournier
Journal:  J Natl Cancer Inst       Date:  1988-09-21       Impact factor: 13.506

8.  Assessment of the critical level of androgen for growth response of transplantable human prostatic carcinoma (PC-82) in nude mice.

Authors:  W M van Weerden; G J van Steenbrugge; A van Kreuningen; E P Moerings; F H de Jong; F H Schröder
Journal:  J Urol       Date:  1991-03       Impact factor: 7.450

9.  Primary orchiectomy versus estrogen therapy in advanced prostatic cancer--a randomized study: results after 7 to 10 years of followup.

Authors:  J E Johansson; S O Andersson; L Holmberg; R Bergström
Journal:  J Urol       Date:  1991-03       Impact factor: 7.450

10.  The inability of adrenal androgens to stimulate the adult human prostate: an autopsy evaluation of men with hypogonadotropic hypogonadism and panhypopituitarism.

Authors:  J E Oesterling; J I Epstein; P C Walsh
Journal:  J Urol       Date:  1986-11       Impact factor: 7.450
View more
  1 in total

1.  Hormonal manipulation of prostatic cancer.

Authors:  M C Bishop
Journal:  BMJ       Date:  1992-01-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.